AMH (anti-Müllerian hormone) testing estimates ovarian reserve, meaning the remaining supply of developing eggs, and can help predict how the ovaries may respond to fertility medicines. It does not prove whether someone can or cannot become pregnant naturally, measure egg quality, diagnose polycystic ovary syndrome (PCOS) by itself, or tell exactly when menopause will begin. A result needs to be interpreted alongside age, history, and other findings.
What does an AMH test actually measure?
An anti-Müllerian hormone (AMH) test measures the amount of this hormone in a blood sample. In the ovaries, AMH is produced by cells surrounding developing egg-containing follicles. The hormone level provides an indirect estimate of ovarian reserve, which refers to the remaining supply of eggs rather than their quality.
AMH is particularly useful when a fertility specialist is planning treatment that stimulates the ovaries to develop multiple eggs. The result can help estimate how the ovaries might respond to fertility medicines. However, it is only one part of the assessment. According to MedlinePlus, an AMH test cannot tell whether the eggs are healthy or reliably predict whether someone will become pregnant.
Which common AMH test myths are misleading?
Myth 1: Low AMH means natural pregnancy is impossible
A lower-than-expected AMH result does not prove that natural pregnancy is impossible. It may suggest a smaller remaining egg supply, but the result does not directly measure whether an egg will be released, fertilized, or develop into a pregnancy.
Some people with lower AMH levels conceive without fertility treatment, while others may need help for reasons that AMH testing cannot identify. Age, ovulation, fallopian tube function, sperm health, and other reproductive factors also matter. The American Society for Reproductive Medicine (ASRM) explains that ovarian reserve tests are poor independent predictors of a person's chances of conceiving naturally.
Myth 2: High AMH means someone is more fertile
A higher AMH result is often associated with a larger ovarian reserve, but it does not establish that a person is more fertile. The test does not measure egg quality, confirm regular ovulation, check whether the fallopian tubes are open, or assess sperm quality.
Higher AMH can also occur in people with polycystic ovary syndrome (PCOS). This condition may affect ovulation, so a higher result should not automatically be interpreted as better reproductive health. AMH is one possible piece of information in an assessment for PCOS, not a diagnosis by itself. MedlinePlus guidance on AMH testing notes that other test results, symptoms, and medical history are needed to evaluate this condition.
Myth 3: AMH tells you how healthy your eggs are
AMH mainly provides information about egg quantity, not egg quality. It does not show whether an individual egg has the normal genetic material needed for healthy embryo development. A result that suggests a larger ovarian reserve does not guarantee healthy eggs, and a lower result does not prove that every remaining egg is unhealthy.
Egg quality and reproductive potential are influenced by factors that AMH does not directly measure, including age. The distinction matters when interpreting fertility results: a test that estimates the remaining egg supply cannot provide a complete picture of whether conception will occur or whether a pregnancy will continue successfully.
Myth 4: AMH gives an exact count of the eggs remaining
AMH is not a direct inventory of every egg in the ovaries. It measures a hormone produced by developing follicles, and clinicians use that information as an indirect marker of ovarian reserve. It cannot provide an exact count of all remaining eggs.
Results also need to be interpreted using the relevant laboratory method, the person's age, and the reason for testing. Different assays may not produce perfectly interchangeable results, so comparing numbers from separate laboratories without clinical context can be misleading. A change between two results does not, by itself, establish how many eggs have been lost.
Myth 5: AMH predicts exactly when menopause will begin
AMH levels generally decline as the ovarian egg supply decreases with age. A lower result may provide information about ovarian reserve, but it cannot accurately tell an individual the date or age when menopause will occur.
Menopause timing depends on the broader pattern of reproductive aging, and one AMH result cannot establish a precise timeline. The American College of Obstetricians and Gynecologists (ACOG) states that AMH testing is not suitable for predicting the onset of menopause in routine clinical practice.
Myth 6: AMH proves whether IVF will succeed or fail
AMH can help a fertility specialist estimate how the ovaries may respond to stimulation medicines during in vitro fertilization (IVF). It can provide useful information about the likely number of eggs that may be collected, including the possibility of a lower-than-expected or stronger-than-expected response.
However, the number of eggs collected is not the same as the chance of having a baby. Fertilization, embryo development, embryo quality, age, sperm factors, and other aspects of treatment also affect outcomes. ASRM emphasizes that ovarian reserve markers predict egg yield more reliably than they predict overall reproductive potential. A low AMH result should not automatically be treated as proof that IVF cannot work or as the sole reason to deny fertility treatment.
What does an AMH result not prove about PCOS or infertility?
AMH results are sometimes used alongside other findings when a clinician evaluates possible PCOS or investigates fertility concerns. However, neither a high nor a low result is enough to establish a diagnosis of infertility. Likewise, a high AMH level alone cannot confirm PCOS, and a low AMH level alone cannot establish that the ovaries have stopped working.
When PCOS is being considered, the clinician reviews relevant symptoms, menstrual patterns, medical history, and other findings. When fertility is the concern, the evaluation may also consider ovulation, reproductive anatomy, sperm factors, and how long pregnancy has been attempted. The combination of these findings is more informative than an isolated AMH number.
How should AMH results be interpreted correctly?
The meaning of an AMH result depends on why the test was ordered. A result that is useful for planning fertility medication may be much less useful for answering questions about natural conception or menopause timing. There is no single AMH number that can answer every fertility question for every person.
A clinician may interpret the result alongside age, menstrual and reproductive history, other hormone tests, and an ultrasound assessment of the small follicles in the ovaries when appropriate. The laboratory's units, reference information, and testing method also matter. If a result differs from an earlier test, the clinician can consider whether the difference is meaningful in the context of the testing methods and the overall clinical picture.
It is also important to distinguish a test's ability to estimate ovarian reserve from its ability to predict pregnancy. According to ASRM guidance on ovarian reserve testing, these markers can be helpful for anticipating ovarian response during fertility treatment, but they are not reliable standalone measures of a person's reproductive potential.
When is AMH testing useful, and what should you ask next?
AMH testing can be useful when a fertility specialist needs information to plan ovarian stimulation or assess ovarian reserve as part of a broader evaluation. It may also be considered in selected clinical assessments involving PCOS or certain ovarian conditions. Its value depends on the question the clinician is trying to answer.
For people who are not seeking fertility treatment, routine AMH testing should not be treated as a definitive forecast of future fertility. A result alone cannot reliably establish how quickly conception will happen or how long someone can wait before trying to conceive. ACOG advises against using AMH to counsel women without infertility about their future reproductive potential on the basis of a single result.
When discussing a result with a healthcare professional, useful questions include:
- What does this result suggest about my ovarian reserve, considering my age and the reason for testing?
- Does the result change any treatment decisions, or is additional information needed first?
- If I am planning pregnancy, what other factors should be assessed to understand my reproductive health?
The key point is that AMH is a useful but limited marker. It can help estimate ovarian reserve and guide certain fertility-treatment decisions, but it does not independently prove natural fertility, egg quality, a PCOS diagnosis, IVF success or failure, or the timing of menopause. Understanding the purpose of the test helps prevent a single laboratory result from being interpreted as a complete picture of reproductive health.